BIOMAT Database Logo BIOMAT Database Logo

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. 1989

K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Department of Medicine, University of California, San Francisco.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004660 Encephalitis Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition. Inflammation, Brain,Rasmussen Syndrome,Brain Inflammation,Encephalitis, Rasmussen,Rasmussen Encephalitis,Rasmussen's Syndrome,Brain Inflammations
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
[Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
February 1992, Nederlands tijdschrift voor geneeskunde,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
January 1994, Pharmacotherapy,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Treatment of acyclovir-resistant herpes simplex virus infections in patients with AIDS.
January 1992, Journal of acquired immune deficiency syndromes,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Acyclovir-resistant herpes simplex virus.
September 1982, The New England journal of medicine,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
[Acyclovir-resistant herpes simplex virus].
September 1990, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
November 1989, Archives of dermatology,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
February 1989, The New England journal of medicine,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
December 2007, International journal of dermatology,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Acyclovir-resistant herpes simplex virus infection.
August 1995, The Journal of infectious diseases,
K S Erlich, and J Mills, and P Chatis, and G J Mertz, and D F Busch, and S E Follansbee, and R M Grant, and C S Crumpacker
Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
February 1992, The American journal of medicine,
Copied contents to your clipboard!